Mumbai, November 27, 20017: Biopharamaceutical major Biocon today said it has launched its cancer biosimilar drug KRABEVA in India.
The product will be used for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers in India,company said in afiling with BSE.
United News of India
